Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-014532
Filing Date
2025-05-23
Accepted
2025-05-23 17:45:17
Documents
2
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 form4-05232025_050513.html 4  
1 form4-05232025_050513.xml 4 4207
2 ex24-05232025_050513.htm EX-24 5730
  Complete submission text file 0001415889-25-014532.txt   11388
Mailing Address 405 LEXINGTON AVENUE 50TH FLOOR NEW YORK NY 10174
Business Address
Kalir Erez (Reporting) CIK: 0001512447 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 25983633

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)